1. AB0802 SAFETY PROFILES OF IXEKIZUMAB VERSUS ADALIMUMAB: 52-WEEK RESULTS FROM A HEAD-TO-HEAD COMPARISON IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS. (2nd June 2020) Authors: Mease, P. J.; Smolen, J. S.; Kavanaugh, A.; Nash, P.; Gallo, G.; Liu Leage, S.; Sapin, C.; Genovese, M. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0841 TARGET OUTCOMES IN PsA: SIMULTANEOUS ACHIEVEMENT of ACR50-PASI100 AND BEYOND: INSIGHTS FROM SPIRIT-H2H AT WEEK 24. (13th June 2020) Authors: Smolen, J. S.; Behrens, F.; Liu Leage, S.; Sapin, C.; De La Torre, I.; Meszaros, G.; Schett, G.; Gossec, L.; Ostor, A.; Combe, B.; Van den Bosch, F. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials. (April 2014) Authors: Michalak, E. E.; Guiraud-Diawara, A.; Sapin, C. Journal: Current medical research and opinion Issue: Volume 30:Number 4(2014:Apr.) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials. (April 2014) Authors: Michalak, E. E.; Guiraud-Diawara, A.; Sapin, C. Journal: Current medical research and opinion Issue: Volume 30:Number 4(2014:Apr.) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0332 EVALUATION OF THE INDIVIDUAL COMPONENTS OF ACR50+PASI100 AND MDA AT WEEK 24 FROM THE SPIRIT-H2H TRIAL COMPARING THE EFFICACY AND SAFETY OF IXE VERSUS ADA IN PATIENTS WITH PSA NAÏVE TO BDMARDS. (2nd June 2020) Authors: Coates, L. C.; Nissen, M.; El Baou, C.; Zochling, J.; Marchesoni, A.; Liu Leage, S.; Soriano, E.; Azevedo, V. F.; Machold, K.; Sapin, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Indirect comparison of clobazam and other therapies for Lennox–Gastaut syndrome. (15th February 2013) Authors: Cramer, J. A.; Sapin, C.; François, C. Journal: Acta neurologica Scandinavica Issue: Volume 128:Number 2(2013:Aug.) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0228 EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB (SPIRIT-H2H) WITH AND WITHOUT CONCOMITANT CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN BIOLOGIC DMARD-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS: 52-WEEK RESULTS. (2nd June 2020) Authors: Smolen, J. S.; Sebba, A.; Ruderman, E.; Gellett, A.; Sapin, C.; Sprabery, A. T.; Liu Leage, S.; Pillai, S.; Reis, P.; Nash, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0290 Effects of biologic dmards on physical function in patients with active psoriatic arthritis: results of network meta-analyses. (12th June 2018) Authors: Ruyssen-Witrand, A.; Sapin, C.; Hartz, S.; Liu Leage, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗